Pregled bibliografske jedinice broj: 1183067
Development of Improved High-Performance Liquid Chromatography Method for the Determination of Residual Caprylic Acid in Formulations of Human Immunoglobulins
Development of Improved High-Performance Liquid Chromatography Method for the Determination of Residual Caprylic Acid in Formulations of Human Immunoglobulins // Molecules, 27 (2022), 1665, 13 doi:10.3390/molecules27051665 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1183067 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Development of Improved High-Performance Liquid
Chromatography Method for the Determination of
Residual Caprylic Acid in Formulations of Human
Immunoglobulins
Autori
Štimac, Adela ; Kurtović, Tihana ; Pavlović, Nediljko ; Halassy, Beata
Izvornik
Molecules (1420-3049) 27
(2022);
1665, 13
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
caprylic acid ; high-performance liquid chromatography method ; convalescent anti-SARS-CoV-2 human plasma ; human immunoglobulins ; validation ; quality control
Sažetak
Quality control of human immunoglobulin formulations produced by caprylic acid precipitation necessitates a simple, rapid, and accurate method for determination of residual caprylic acid. A high-performance liquid chromatography method for that purpose was developed and validated. The method involves depletion of immunoglobulins, the major interfering components that produce high background noise, by precipitation with acetonitrile (1:1, v/v). Chromatographic analysis of caprylic acid, preserved in supernatant with no loss, was performed using a reverse-phase C18 column (2.1 × 150 mm, 3 μm) as a stationary phase and water with 0.05% TFA–acetonitrile (50:50, v/v) as a mobile phase at a flow rate of 0.2 mL/min and run time of 10 min. The developed method was successfully validated according to the ICH guidelines. The validation parameters confirmed that method was linear, accurate, precise, specific, and able to provide excellent separation of peaks corresponding to caprylic acid and the fraction of remaining immunoglobulins. Furthermore, a 24−1 fractional factorial design was applied in order to test the robustness of developed method. As such, the method is highly suitable for the quantification of residual caprylic acid in formulations of human immunoglobulins for therapeutic use, as demonstrated on samples produced by fractionation of convalescent anti-SARS-CoV-2 human plasma at a laboratory scale. The obtained results confirmed that the method is convenient for routine quality control.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
HRZZ-IP-CORONA-IP-CORONA-2020-04-2053 - Stvaranje preduvjeta za uvođenje SARS-CoV-2 seroterapije u Hrvatskoj (Halassy, Beata, HRZZ - 2020-04) ( CroRIS)
EK-KK.01.1.1.01.0006 - Jačanje kapaciteta CERVIRVAC-a za istraživanja u virusnoj imunologiji i vakcinologiji (Jonjić, Stipan, EK ) ( CroRIS)
Ustanove:
Imunološki zavod d.d.,
Sveučilište u Zagrebu
Profili:
Beata Halassy
(autor)
Tihana Kurtović
(autor)
Adela Štimac
(autor)
Nediljko Pavlović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE